Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Wilson

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Therapeutic Innovation & Regulatory Science|September 21, 2018
Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma's Approach, Part 1Brett Wilson, Tom Provencher, Jacqueline Gough, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Optimizing the Use of Electronic Data Sources in Clinical Trials: The Technology LandscapeEd Kellar, Susan Bornstein, Aleny Caban, et al.
Vox Sanguinis|September 14, 2022
Fatal haemolytic transfusion reaction due to anti-En<sup>a</sup> and identification of a novel GYPA c.295delG variant in a Thai familyPloymanee Suwanwootichai, Genghis H Lopez, Morakot Emthip, et al.
Asian Journal of Transfusion Science|July 22, 2024
A<sub>weak</sub> phenotype associated with novel ABO*A allele variant c.106delinsGGSanmukh Ratilal Joshi, Glenda Millard, Mayuri Vekariya, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape, Part 1Ed Kellar, Susan M Bornstein, Aleny Caban, et al.
Transfusion Medicine (Oxford, England)|November 9, 2023
Recurrent pregnancy loss in a patient with anti-Rh17Bushra Moiz, Muhammed Salman, Seher Rasheed, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|September 5, 2020
Frequency of Mi<sup>a</sup> (MNS7) and Classification of Mi<sup>a</sup>-Positive Hybrid Glycophorins in an Australian Blood Donor PopulationGenghis H Lopez, Brett Wilson, Robyn M Turner, et al.
Vox Sanguinis|April 12, 2022
A new high-prevalence LW antigen detected by an antibody in an Indigenous Australian homozygous for LW*A c.309C>A variantGenghis H Lopez, Brett Wilson, Glenda M Millard, et al.
Transfusion|September 5, 2022
Hemolytic disease of the fetus and newborn caused by anti-s<sup>D</sup> antibody in a GP.Mur/Mur Thai mother and review of the prevalence of s<sup>D</sup> in Thai blood donorsGenghis H Lopez, Morakot Emthip, Ploymanee Suwanwootichai, et al.
Transfusion|November 10, 2017
Targeted exome sequencing defines novel and rare variants in complex blood group serology cases for a red blood cell reference laboratory settingElizna M Schoeman, Eileen V Roulis, Yew-Wah Liew, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Therapeutic Innovation & Regulatory Science|September 21, 2018
Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma's Approach, Part 1Brett Wilson, Tom Provencher, Jacqueline Gough, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Optimizing the Use of Electronic Data Sources in Clinical Trials: The Technology LandscapeEd Kellar, Susan Bornstein, Aleny Caban, et al.
Vox Sanguinis|September 14, 2022
Fatal haemolytic transfusion reaction due to anti-En<sup>a</sup> and identification of a novel GYPA c.295delG variant in a Thai familyPloymanee Suwanwootichai, Genghis H Lopez, Morakot Emthip, et al.
Asian Journal of Transfusion Science|July 22, 2024
A<sub>weak</sub> phenotype associated with novel ABO*A allele variant c.106delinsGGSanmukh Ratilal Joshi, Glenda Millard, Mayuri Vekariya, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape, Part 1Ed Kellar, Susan M Bornstein, Aleny Caban, et al.
Transfusion Medicine (Oxford, England)|November 9, 2023
Recurrent pregnancy loss in a patient with anti-Rh17Bushra Moiz, Muhammed Salman, Seher Rasheed, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|September 5, 2020
Frequency of Mi<sup>a</sup> (MNS7) and Classification of Mi<sup>a</sup>-Positive Hybrid Glycophorins in an Australian Blood Donor PopulationGenghis H Lopez, Brett Wilson, Robyn M Turner, et al.
Vox Sanguinis|April 12, 2022
A new high-prevalence LW antigen detected by an antibody in an Indigenous Australian homozygous for LW*A c.309C>A variantGenghis H Lopez, Brett Wilson, Glenda M Millard, et al.
Transfusion|September 5, 2022
Hemolytic disease of the fetus and newborn caused by anti-s<sup>D</sup> antibody in a GP.Mur/Mur Thai mother and review of the prevalence of s<sup>D</sup> in Thai blood donorsGenghis H Lopez, Morakot Emthip, Ploymanee Suwanwootichai, et al.
Transfusion|November 10, 2017
Targeted exome sequencing defines novel and rare variants in complex blood group serology cases for a red blood cell reference laboratory settingElizna M Schoeman, Eileen V Roulis, Yew-Wah Liew, et al.
Pageof 3